FDA Approves Moderna's First mRNA Flu Vaccine for Older Adults
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, Fluarix, marking the first mRNA flu shot to be authorized. This new vaccine is specifically geared towards protecting millions of older Americans against influenza.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (100/100)Sources
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The agency had initially refused to even review the application but reversed course after a public outcry.
By Christina Jewett
Read full article →The mRNA technology behind Moderna’s Covid vaccine reaches the flu
The mFlusiva vaccine for older people is first made with mRNA platform key to ending coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic, Moderna, the manufacturer, said. The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu shots already have begun arriving in pharmacies ahead of fall vaccination season, and Mode...
By Associated Press
Read full article →A new flu vaccine geared to older people is coming soon
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
By Rob Stein
Read full article →FDA approves first-ever mRNA flu vaccine for millions of older Americans
A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early regulatory setback.
Read full article →U.S. FDA approves first mRNA flu shot from Moderna
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older.
Read full article →FDA Approves First MRNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
By Siladitya Ray, Forbes Staff
Read full article →Moderna's mRNA Flu Vaccine Approved By FDA
Moderna's mRNA Flu Vaccine Approved By FDA Authored by Rachel Roberts via The Epoch Times, The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal influenza. Moderna bivalent COVID-19 vaccine at a clinic, in Richmond, Va., on November 17, 2022. AP Photo/Steve Helber, File The shot, known as mFlusiva, was given a traditional approval for adults ag...
By Tyler Durden
Read full article →
